ATAI
Price:
$1.61
Market Cap:
$270.16M
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder...[Read more]
Industry
Biotechnology
IPO Date
2021-06-18
Stock Exchange
NASDAQ
Ticker
ATAI
According to Atai Life Sciences N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 264.01M. This represents a change of 19.93% compared to the average of 220.13M of the last 4 quarters.
The mean historical Enterprise Value of Atai Life Sciences N.V. over the last ten years is 259.85M. The current 264.01M Enterprise Value has changed 10.06% with respect to the historical average. Over the past ten years (40 quarters), ATAI's Enterprise Value was at its highest in in the December 2020 quarter at 2.87B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
259.85M
Median
198.06M
Minimum
-19993485.76
Maximum
864.44M
Discovering the peaks and valleys of Atai Life Sciences N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.70%
Maximum Annual Enterprise Value = 864.44M
Minimum Annual Increase = -190.07%
Minimum Annual Enterprise Value = -19993485.76
Year | Enterprise Value | Change |
---|---|---|
2023 | 198.06M | -17.03% |
2022 | 238.72M | -72.38% |
2021 | 864.44M | 4.70% |
2020 | 18.01M | -190.07% |
The current Enterprise Value of Atai Life Sciences N.V. (ATAI) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
433.74M
5-year avg
259.85M
10-year avg
259.85M
Atai Life Sciences N.V.’s Enterprise Value is less than Mind Medicine (MindMed) Inc. (283.41M), greater than Seelos Therapeutics, Inc. (10.08M), less than GH Research PLC (392.97M), greater than Freeline Therapeutics Holdings plc (2.82M), greater than Cybin Inc. (120.27M), greater than Fortress Biotech, Inc. (57.12M), greater than Bio-Path Holdings, Inc. (3.00M), greater than Vaccinex, Inc. (6.56M), greater than Eliem Therapeutics, Inc. (119.64M), less than Opthea Limited (514.42M), greater than Molecular Partners AG (132.68M), less than Edgewise Therapeutics, Inc. (3.01B), greater than iTeos Therapeutics, Inc. (185.75M), greater than Wesana Health Holdings Inc. (336.60K), greater than BioVaxys Technology Corp. (17.41M), greater than Algernon Pharmaceuticals Inc. (1.14M), greater than AXIM Biotechnologies, Inc. (7.01M),
Company | Enterprise Value | Market cap |
---|---|---|
283.41M | $554.39M | |
10.08M | $214.97K | |
392.97M | $482.30M | |
2.82M | $28.28M | |
120.27M | $196.32M | |
57.12M | $44.44M | |
3.00M | $3.53M | |
6.56M | $9.41M | |
119.64M | $342.68M | |
514.42M | $486.27M | |
132.68M | $219.11M | |
3.01B | $3.05B | |
185.75M | $303.96M | |
336.60K | $149.67K | |
17.41M | $12.75M | |
1.14M | $1.25M | |
7.01M | $603.92K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atai Life Sciences N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Atai Life Sciences N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Atai Life Sciences N.V.'s Enterprise Value?
What is the highest Enterprise Value for Atai Life Sciences N.V. (ATAI)?
What is the 3-year average Enterprise Value for Atai Life Sciences N.V. (ATAI)?
What is the 5-year average Enterprise Value for Atai Life Sciences N.V. (ATAI)?
How does the current Enterprise Value for Atai Life Sciences N.V. (ATAI) compare to its historical average?